Reduction of Specific Circulating Lymphocyte Populations with Metabolic Risk Factors in Patients at Risk to Develop Type 2 Diabetes

Open Access

Peer-reviewed

Research Article

Helena Cucak,

Affiliation Hagedorn Research Institute. Department of Diabetic Complications Biology Novo Nordisk A/S, Måløv, Denmark
⨯
Dorte Vistisen,

Affiliation Department of Clinical Epidemiology, Steno Diabetes Center, Gentofte, Denmark
⨯
Daniel Witte,

Affiliation Department of Clinical Epidemiology, Steno Diabetes Center, Gentofte, Denmark
⨯
Annelotte Philipsen,

Affiliation Department of Clinical Epidemiology, Steno Diabetes Center, Gentofte, Denmark
⨯
Alexander Rosendahl

* E-mail: axrd@novonordisk.com

Affiliation Hagedorn Research Institute. Department of Diabetic Complications Biology Novo Nordisk A/S, Måløv, Denmark
⨯

Reader Comments (0)

T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
B cells
Is the Subject Area "B cells" applicable to this article?

Thanks for your feedback.
Food
Is the Subject Area "Food" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Monocytes
Is the Subject Area "Monocytes" applicable to this article?

Thanks for your feedback.
Blood
Is the Subject Area "Blood" applicable to this article?

Thanks for your feedback.
Regulatory T cells
Is the Subject Area "Regulatory T cells" applicable to this article?

Thanks for your feedback.
Inflammation
Is the Subject Area "Inflammation" applicable to this article?

Thanks for your feedback.